Why was UnitedHealth's Q1 2024 GAAP result a net loss when revenue grew?

The net loss of $1.53 per diluted share was driven mainly by an approximately $7.1 billion loss on the sale of the Brazil operations, most of which was a noncash charge tied to cumulative foreign currency translation losses. Cyberattack costs also weighed on results, with $0.74 per share of total impact in the quarter.

What is the difference between GAAP and adjusted EPS for this quarter?

Adjusted EPS of $6.91 excludes the Brazil sale loss, intangible amortization, and direct response costs of the Change Healthcare cyberattack, but includes the $0.25 per share of business disruption impacts. Management views these exclusions as better reflecting underlying business performance, though investors should weigh the excluded items as real costs.

Is the cyberattack impact on full-year 2024 earnings expected to be contained?

The company estimates total full-year 2024 cyberattack impacts of $1.15 to $1.35 per share, including direct response costs and $0.30 to $0.40 per share of business disruption impacts. Adjusted EPS guidance of $27.50 to $28.00 was maintained, but the GAAP outlook was reduced to $17.60 to $18.20 to reflect the Brazil sale and direct response costs.

Why did operating cash flow fall so sharply?

Operating cash flow was $1.1 billion versus $16.3 billion a year earlier. Management attributed about $3 billion of the decline to cyberattack response actions, including accelerated payments to care providers, and to the timing of public sector cash receipts.

Are there signs of pressure in medical costs and reserves?

Yes. The medical care ratio rose to 84.3% from 82.2%, and the company added $800 million in precautionary claims reserves because the cyberattack could affect claims receipt timing. Medical costs payable increased $1.6 billion from year-end 2023 to $34 billion, with incurred but not yet reported claims up $3 billion.

UNH 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed April 16, 2024. Cited figures are marked; the original filing is the authoritative source.

UnitedHealth Group reported first quarter 2024 revenue of $99.8 billion^a, up nearly $8 billion year over year, with growth led by Optum Health, Optum Rx and UnitedHealthcare, which added people served.

GAAP results were a net loss of $1.53^b per diluted share, driven mainly by a roughly $7.1 billion loss on the February 2024 sale of the Brazil operations, largely noncash and tied to cumulative foreign currency translation losses. Adjusted EPS rose to $6.91 from $6.26, though that figure includes $0.25 per share of Change Healthcare business disruption impacts. The cyberattack on Change Healthcare cost $0.74 per share in the quarter, with $0.49 in direct response costs and $0.25 in business disruption impacts.

The quarter's core operating picture was softer than the headline growth suggests. The medical care ratio rose to 84.3% from 82.2% a year earlier, reflecting Medicare funding reductions, cyberattack-related accommodations to care providers, and an additional $800 million^c of precautionary claims reserves. Operating cash flow fell to $1.1 billion from $16.3 billion, with about $3 billion attributed to cyberattack response actions, including accelerated provider payments, and timing of public sector receipts.

The company still returned $4.8 billion^d to shareholders through dividends and buybacks. Full-year GAAP EPS guidance was lowered to $17.60 to $18.20 to reflect the Brazil sale and direct response costs, while adjusted EPS guidance of $27.50 to $28.00 was maintained.

For investors, the key questions are the pace of Change Healthcare restoration, whether cyberattack costs stay within the estimated $1.15 to $1.35 per share full-year range, and whether cash flow normalizes as accelerated provider payments unwind. Medical cost trends and the medical care ratio, along with Medicaid eligibility redetermination effects on UnitedHealthcare membership, will also be important to monitor.

02—Key points

Key Highlights

Revenue reached $99.8 billion, up from $91.9 billion a year earlier, led by Optum and UnitedHealthcare membership growth.
GAAP diluted EPS was a net loss of $1.53, primarily due to the approximately $7.1 billion loss on the Brazil sale; adjusted EPS was $6.91 versus $6.26 in the prior-year quarter.
Total cyberattack impacts were $0.74 per share in Q1, including $0.49 in direct response costs and $0.25 in business disruption impacts; full-year 2024 total impact is estimated at $1.15 to $1.35 per share.
Medical care ratio increased to 84.3% from 82.2%, driven by Medicare funding reductions, cyberattack-related provider accommodations, an extra $800 million in claims reserves, and business mix.
Operating cash flow dropped to $1.1 billion from $16.3 billion, with roughly $3 billion attributed to cyberattack response, including accelerated care provider funding.
Full-year GAAP EPS guidance was lowered to $17.60 to $18.20, while adjusted EPS guidance of $27.50 to $28.00 was maintained.
Shareholder returns totaled $4.8 billion in Q1 through dividends and share repurchases, and over $6 billion in advance funding and interest-free loans has been provided to care providers.

03—Questions

Frequently Asked Questions

Why was UnitedHealth's Q1 2024 GAAP result a net loss when revenue grew?
The net loss of $1.53 per diluted share was driven mainly by an approximately $7.1 billion loss on the sale of the Brazil operations, most of which was a noncash charge tied to cumulative foreign currency translation losses. Cyberattack costs also weighed on results, with $0.74 per share of total impact in the quarter.
What is the difference between GAAP and adjusted EPS for this quarter?
Adjusted EPS of $6.91 excludes the Brazil sale loss, intangible amortization, and direct response costs of the Change Healthcare cyberattack, but includes the $0.25 per share of business disruption impacts. Management views these exclusions as better reflecting underlying business performance, though investors should weigh the excluded items as real costs.
Is the cyberattack impact on full-year 2024 earnings expected to be contained?
The company estimates total full-year 2024 cyberattack impacts of $1.15 to $1.35 per share, including direct response costs and $0.30 to $0.40 per share of business disruption impacts. Adjusted EPS guidance of $27.50 to $28.00 was maintained, but the GAAP outlook was reduced to $17.60 to $18.20 to reflect the Brazil sale and direct response costs.
Why did operating cash flow fall so sharply?
Operating cash flow was $1.1 billion versus $16.3 billion a year earlier. Management attributed about $3 billion of the decline to cyberattack response actions, including accelerated payments to care providers, and to the timing of public sector cash receipts.
Are there signs of pressure in medical costs and reserves?
Yes. The medical care ratio rose to 84.3% from 82.2%, and the company added $800 million in precautionary claims reserves because the cyberattack could affect claims receipt timing. Medical costs payable increased $1.6 billion from year-end 2023 to $34 billion, with incurred but not yet reported claims up $3 billion.

04—Continue

← View all 8-K filings